Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Julius Clinical logo — Julius Clinical manages global clinical drug trials that wil...

Julius Clinical

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference

Founded 2008 The Netherlands The Netherlands 176 employees Private Equity Health Care, Pharmaceutical

General Information

Company Name Julius Clinical
Founded Year 2008
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 176
Industries Health Care, Pharmaceutical
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Julius Clinical. To contact Julius Clinical, visit juliusclinical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Julius Clinical compare?

A PDF of Julius Clinical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Julius Clinical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Julius Clinical

Julius Clinical is a health care and pharmaceutical startup founded in 2008 and headquartered in The Netherlands. The company manages global clinical drug trials with the objective of making a significant impact on medicine and people's lives, as highlighted by their slogan, "Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference." The company's approach is characterized by a strong emphasis on science, flexibility, creativity, innovation, and skilled networks of investigators globally. It collaborates with leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators, to conduct clinical trials in therapeutic areas such as cardiology, diabetes, CNS, and infectious diseases. The latest investment in Julius Clinical came in the form of a Private Equity Round at 28 November 2023 from Ampersand Capital Partners. The substantial global reach and reputation of the company are facilitated by its internationally recognized academic leaders and personal links with peers worldwide. This extensive network enables the company to efficiently select high-performing sites for trials and maintain motivated investigators. In summary, Julius Clinical stands out as a company that combines scientific expertise with operational efficiency to deliver impactful results in the field of clinical trials.

Business keywords: clinical drug trials, global reach, scientific approach, clinical development programs, pharmaceutical, biotech, medical device, academic investigators, cardiology, diabetes, CNS, infectious diseases, global reputation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Ampersand Capital Partners
Ampersand Capital Partners
28 Nov 2023

Julius Clinical Alternatives & Competitors

View All Alternatives
Julius Clinical vs
CervoMed
CervoMed United States

Medicines for the Brain.

Post-IPO Debt
20 employees
Health Care, Pharmaceutical
Compare Julius Clinical vs CervoMed
Julius Clinical vs
Romark, L.C.
Romark, L.C. United States

Positively impacting the lives of people worldwide

Debt Financing
75 employees
Health Care, Pharmaceutical
Compare Julius Clinical vs Romark, L.C.
Julius Clinical vs
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. United States

Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with h...

Post-IPO Equity
384 employees
Health Care, Pharmaceutical
View all alternatives

FAQ About Julius Clinical

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference
Julius Clinical was founded in 2008.
Julius Clinical is headquartered in The Netherlands.
Julius Clinical operates in Health Care and Pharmaceutical. Its work centres on clinical drug trials, global reach, scientific approach and clinical development programs.
Julius Clinical has approximately 176 employees.
Julius Clinical has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to Julius Clinical include CervoMed, Romark, L.C., Karyopharm Therapeutics Inc., ZabBio, Inc., Cinclus Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Julius Clinical and CervoMed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Julius Clinical, https://bouncewatch.com/company/julius-clinical, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout